CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $428,000 | -16.6% | 237,835 | -6.3% | 0.00% | 0.0% |
Q1 2022 | $513,000 | -24.1% | 253,932 | +1.8% | 0.00% | 0.0% |
Q4 2021 | $676,000 | -54.6% | 249,350 | -25.3% | 0.00% | -50.0% |
Q3 2021 | $1,489,000 | -15.9% | 333,867 | +9.4% | 0.00% | 0.0% |
Q2 2021 | $1,770,000 | -3.4% | 305,159 | +16.9% | 0.00% | -33.3% |
Q1 2021 | $1,832,000 | +15.9% | 261,037 | -20.7% | 0.00% | 0.0% |
Q4 2020 | $1,580,000 | +47.4% | 329,109 | +79.0% | 0.00% | 0.0% |
Q3 2020 | $1,072,000 | +155.8% | 183,819 | +552.4% | 0.00% | -25.0% |
Q2 2019 | $419,000 | -61.6% | 28,174 | -35.8% | 0.00% | -66.7% |
Q1 2019 | $1,090,000 | +37.1% | 43,907 | -0.9% | 0.01% | +71.4% |
Q4 2018 | $795,000 | +30.1% | 44,285 | +112.9% | 0.01% | +40.0% |
Q3 2018 | $611,000 | -48.5% | 20,804 | -20.3% | 0.01% | -50.0% |
Q2 2018 | $1,187,000 | -27.0% | 26,104 | -15.2% | 0.01% | -37.5% |
Q1 2018 | $1,625,000 | -8.8% | 30,782 | +17.5% | 0.02% | +23.1% |
Q4 2017 | $1,781,000 | -79.5% | 26,196 | -75.1% | 0.01% | -83.5% |
Q3 2017 | $8,685,000 | +8.1% | 105,400 | +22.8% | 0.08% | -4.8% |
Q2 2017 | $8,034,000 | +192.4% | 85,811 | +98.8% | 0.08% | +159.4% |
Q1 2017 | $2,748,000 | +2228.8% | 43,163 | +1519.0% | 0.03% | +3100.0% |
Q4 2016 | $118,000 | -21.3% | 2,666 | -35.8% | 0.00% | -50.0% |
Q3 2016 | $150,000 | -58.4% | 4,154 | -77.9% | 0.00% | -60.0% |
Q1 2016 | $361,000 | -66.1% | 18,816 | -38.1% | 0.01% | -61.5% |
Q4 2015 | $1,064,000 | -49.6% | 30,397 | +32.3% | 0.01% | -55.2% |
Q3 2015 | $2,113,000 | +665.6% | 22,977 | +244.7% | 0.03% | +625.0% |
Q2 2014 | $276,000 | -56.7% | 6,666 | -27.6% | 0.00% | -63.6% |
Q1 2014 | $637,000 | +137.7% | 9,201 | +106.6% | 0.01% | +175.0% |
Q4 2013 | $268,000 | – | 4,454 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |